Introduction: Apolipoprotein E (APOE) 2 and 4 alleles encoded by rs7412 and rs429358 polymorphisms, respectively, are landmark contra and pro "risk" factors for Alzheimer's disease (AD).
framework of evolutionary biology, age-related traits are viewed as the results of indirect mechanisms such as co-evolution with fast-evolving pathogens, mismatch with environments, reproductive success at the expense of health, and so on, 7 that increase heterogeneity.
Following the framework of evolutionary biology, we examined the molecular signatures of AD in the APOE region, represented by 32 single nucleotide polymorphisms (SNPs) from five genes (BCAM, NECTIN2, TOMM40, APOE, and APOC1), as differences in linkage disequilibrium (LD) patterns in mega-samples of 2673 AD-affected and 16,246 ADunaffected subjects of European ancestry. We emphasized protective and detrimental heterogeneous signatures involving the APOE 2 and 4 alleles, encoded by rs7412 and rs429358, respectively. We show that susceptibility to AD is the result of a complex interplay of these SNPs with SNPs from other genes in the APOE region, which is not driven by common evolutionary forces characteristic for the general (AD-unaffected) population. 
METHODS

Data availability
Study cohorts and phenotypes
We used data from five studies. Data for older individuals were drawn from the Framingham Heart Study (FHS) original (FHS_C1) and offspring (FHS_C2) cohorts, 13 Cardiovascular Health Study (CHS), 14 Health and Retirement Study (HRS), 15 
Genotypes
Genotyping was performed using the same customized Illumina iSelect array (the IBC-chip, ≈50 K SNPs) in the FHS and CHS cohorts, Table S1 ).
Statistical analysis
Associations between AD and each selected SNP were evaluated using an additive genetic model, with the minor allele as an effect allele.
Given limited information on AD age at onset in the LOADFS, the associations in this study were characterized using a logistic model with AD as a binary outcome and random effects to adjust for potential familial clustering (gee package in R). Associations in the other studies were 
Linkage disequilibrium analysis
We have used methods detailed in Ref. 19 . In brief, LD was characterized by the correlation coefficient r using haplotype-based and genotype-based methods. Differences in their LD estimates indicate deviation from Hardy-Weinberg equilibrium (HWE). This information is important because HWE in the entire sample does not guarantee HWE in subsamples and/or at the haplotype level (see below), and thus, the observed deviation from HWE may be biologically plausible. Significance of the LD estimates was characterized using chi-square statistics, defined as 2 = r 2 N, where N = 2n is the number of gametes and n is the sample size. Given the potential loss of power because of inferring haplotypes from genotypes, we used a more conservative estimate, with n instead of N. We employed an LD contrast test 20 to compare the LD estimates between the AD-affected and unaffected groups. This test was used to characterize the significance of the differences in pairwise estimates of LD between these two groups. Significance of the r 2 estimates and the differences in the pairwise estimates of LD were corrected for multiple testing. For the 32 SNPs examined, this represented 496 (=32 × 31/2) tests. We adopted a conservative Bonferroni correction for significance, P ≤ 10 −4 , despite some correlation between these SNPs. Asymptotically valid confidence intervals were constructed using asymptotic variance adapted from. 21 
Functional annotation
RESULTS
Study overview
Molecular signatures of AD were examined as the difference of LD patterns in mega-samples of AD-affected and unaffected subjects of Caucasian ancestry, with men and women combined and separately pooled from four independent studies comprising five cohorts: LOADFS, HRS, CHS, FHS_C1, and FHS_C2 (Table 1) . LD patterns were characterized by 32 non-proxy SNPs (defined as LD with r 2 < 0.8), representing the BCAM, NECTIN2, TOMM40, APOE, and APOC1 genes in the 19q13.3
region (Table S1 ) including two SNPs, rs429358 and rs7412 SNPs, whose minor alleles encode the APOE 4 and 2 alleles, respectively.
We examined the potential role of survival selection in the AD signatures by contrasting LD patterns between older AD-unaffected individuals from those five cohorts (who were at exponentially increased mortality risk) and younger individuals (who were at negligible mortality risk), enriched by subjects from two additional cohorts, FHS_C3 and CARDIA (Table 1) .
Unless explicitly stated, the results of LD analyses are presented using a haplotype-based method (details in Materials and Methods).
Of the examined 32 SNPs, the minor allele of rs429358 was associated with the highest risks of AD development, = 1.26, P = 8.05 (Table S1 ). The effect directions were consistent in all studies for rs429358, but not for rs7412. The largest magnitude of effects for these SNPs was observed in LOADFS ( = 1.78, P = 9.33 × 10 −97 for rs429358 and = −1.50, P = 2.77 × 10 −14 for rs7412) and the smallest in FHS_C1 ( = 0.51, P = 1.87 × 10 −3 for rs429358 and = 0.10, P = 6.48 × 10 −1 for rs7412) ( Figure 1 ).
Molecular signature of Alzheimer's disease
We contrasted LD patterns of the entire APOE region between ADaffected and unaffected individuals (Table S2 ) and found that they differed significantly (P < 2 × 10 −4 ). The pattern of the difference represents a molecular signature of AD illustrated by a heat map for Δr = r cases − r non-cases ( Figure 2 ). Figure 2 shows the complex rearrangement of LD in AD cases compared with non-cases spanning the entire region.
Our analysis identified 193 of 496 (=32 × 31/2) SNP pairs (38.9%)
with Δr values significant at the Bonferroni-adjusted level: P ≤ P Bonf = 10 −4 . For 33 additional SNP pairs, we observed suggestive signifi-
Molecular signatures of AD estimated using the genotype-based method (Table S3 ) were qualitatively the same as those estimated using the haplotype-based method, with significant differences observed between cases and non-cases (P < 2 × 10 −4 ). The genotype-based method provided 153 SNP pairs significant at P < P Bonf and 33 additional SNP pairs with suggestive significance (P Bonf < P < 10 −3 ).
For 149 SNP pairs, the estimates of Δr were significant at P ≤ P Bonf in both the haplotype-and genotype-based methods. Given that all SNPs in the large sample of non-cases were in HWE at P HW > 10 −3 , the discordant estimates of Δr for 44 SNP pairs between these two methods indicated SNPs with a plausible biological role because the deviation from HWE occurs in cases (Table S1 ) and/or at the haplotype level, that is, when Δ AB ≠ D AB (see Materials and Methods). Accordingly, important biologically plausible information can be missed using the genotype-based method alone.
The APOE 2 (rs7412) and 4 (rs429358) coding SNPs are parts of the molecular signature of AD
In non-cases, rs7412 and rs429358 SNPs were in significant LD between each other, r = 11.6%, P = 7.95 × 10 −94 , and with most of the other SNPs (Table S2 ). The strongest LD for rs429358 was observed with rs2075650 (r = 70%, TOMM40) and rs12721046 (r = 69%, APOC1)
SNPs. For rs7412, the strongest LD of r = 37% was with rs283813 (NECTIN2). SNPs. This is because LD between these 8 or 13 SNPs can be very small (Figure 3 , brackets) and, therefore, it cannot be explained by clustering of specific alleles from different SNPs in the same subjects. The latter implies genetic heterogeneity. The changes in LD between AD cases and non-cases observed for rs7412 and rs429358 in the mega sample of pooled studies were consistent in independent studies (Table   S4 ). Consistency of changes in LD for other SNPs in independent studies was reported in Ref. 22.
Rearrangement of LD between AD cases and non-cases
Molecular signatures of AD in men and women
We evaluated LD structure for the selected 32 SNPs in AD-affected and unaffected men and women separately (Table S5 ). The 95% confidence intervals for Δr in men and women well overlapped for all F I G U R E 2 Molecular signature of Alzheimer's disease (AD). Upper-left triangle: Linkage disequilibrium (LD) pattern (r, %) in the pooled sample from all studies, non-cases, for 32 single nucleotide polymorphisms (SNPs). Lower-right triangle: Heat map for Δr = r cases −r non-cases representing the molecular signature of AD. Red denotes r cases > r non-cases and blue denotes r cases < r non-cases . Purple and yellow show the estimates with opposite signs of r cases and r non-cases . For convenience, positive sign of r non-cases has been selected. Legend on the right shows color-coded P-values. The heat map shows that LD changes for the vast majority of SNPs in the entire region spanning all five genes. Numerical estimates are shown in Table S2 SNP pairs, implying no significant difference in Δr between these sexes.
LD patterns in younger and older individuals
We examined the role of survival selection in the molecular signature of AD by contrasting LD patterns in older subjects with no AD who were 55 years and older at biospecimen collection (N = 14,803), and younger subjects who were <55 years at biospecimen collection (N = 6565). We excluded four SNPs from this analysis (rs7026, rs4803760, rs440277, and rs11667640) because they were imputed for most subjects (95.4%) from the young group. The 55-year cutoff was used to separate younger individuals who were under negligible mortality risk in modern developed countries from those who were under exponentially increasing mortality risk. This choice allowed consideration of LD patterns in the younger group as a proxy for the evolutionary selected LD structure in the APOE genomic region. This analysis did not identify significant differences in LD patterns between these two groups. At the level of individual SNP pairs, only two pairs in the BCAM-NECTIN2 locus exhibited significant differences (Δr yo = r youmg − r old at P ≤ P Bonf = 10 −4 ) in these large samples (Table S6) . No significant differences were identified in the TOMM40-APOE-APOC1 locus (Figure 4 ).
Regulatory architecture in the APOE region across cell types and tissues
Using data from Ensembl, 10 of 32 SNPs were identified as regulatory variants in active expression states in a variety of tissues Table  S6 ranging from one to 63 of the 68 cell types ( Table 2 ). For seven of them, RegulomeDB assigned functionality scores of 1b to 2a corresponding to strong regulatory potential ( Table 2 ). Most SNPs may affect transcription factor (TF) binding ability. Altered motifs for TFs were identified for 28 SNPs in HaploReg (Table S7 ). The protein motifs at these sites are for known TFs that could contribute to the complex regulation of genes in this region. HaploReg showed that 10 SNPs could affect the binding of various proteins (from one to seven), suggesting that they could be in actively transcribed regions. Five more SNPs affected protein binding according to RegulomeDB (Table S7 ). Twentysix SNPs acted as eQTLs for the nearby protein-coding genes, according to GTEx, affecting expression in a number of tissues ( Table 2 and Table S7 ).
The APOE 4 allele-related LD cluster ( Figure 3B ) includes five SNPs located in promoter regions of the associated genes, which were active in 5 to 63 of 68 cell types ( 
DISCUSSION
Unlike few small-scale prior studies examining associations of LD patterns with AD, 25, 26 we found that AD was associated with a highly heterogeneous molecular signature in the APOE region, which included rs7412 and rs429358 encoding the 2 and 4 alleles, respectively, and SNPs from all five genes in the BCAM-APOC1 locus, regardless of genomic distance between them. This signature is represented by the pattern of differences in LD structures between AD-affected and unaffected subjects (Figure 2) . The AD signature is consistent with a haplotype rather than a single allele origin of AD. [27] [28] [29] Significant changes in LD indicate complex genetic architecture of AD in this region that is consistent with the view on AD as a continuum, rather than distinct clinically defined entities, driven by multimodal cognitive decline. 30 innate immunity, can contribute to the immune response in the central nervous system (CNS) along with brain-resident macrophages (microglia). 33 A pro-inflammatory (M1) macrophage response causes neurotoxicity. 34 Enrichment in these specific immune cells is consistent with the role of peripheral monocytes/macrophages, along with microglia, in A clearance and a potential role in AD. 33, 35 It is important to note that our results are in line with recent advances implicating monocyte-specific eQTLs in AD 36 and the AD susceptibility alleles as significant eQTLs in CD14 + monocytes. 37 Given crosstalk between macrophages/microglia and astrocytes, they show neurotoxic or neuroprotective phenotypes. M1 macrophages particularly induce astrocyte proliferation and a reactive phenotype. The interaction between macrophages and astrocytes plays an important role in the increasing inflammatory response leading to neurodegeneration. 38 Astrocytes are implicated in the induction of neuroinflammation and AD, and apoE-mediated A clearance, which may be impaired by the reactive phenotype. 39 Stressed, dysfunctional astrocytes are connected with 4-associated AD. 40 A common feature of regulatory variants in the 2 allelerelated LD cluster is having an active or poised state in NHLFs.
Lung fibroblasts play a role in airway inflammation and remodeling. Pulmonary health is important in risk prevention of cognitive decline and dementia. 41 In addition, rs4803760 (intergenic NECTIN2-BCAM) and rs519113 (NECTIN2) are eQTLs for BCAM in lung. The 4-and 2-allele LD clusters have two common promoter variants (rs440446 and rs439401). Of interest, rs439401 is located in the APOE-APOC1 intergenic region, which includes a specific macrophage, adipocyte, and astrocyte enhancer for the APOE gene, 42 and the peroxisome proliferator-activated receptor (PPAR ) regulatory region, 42 which may simultaneously affect transcriptional regulation. PPAR is implicated in the regional transcriptional regulation of chr19q13.32 with the highest increase in expression observed for APOE messenger RNA (mRNA). 42, 43 It plays a role in determining antiinflammatory macrophage (M2) phenotype, 44 astrocyte inflammatory brain pathology, 45 and airway and lung inflammation. 46 Thus 
